Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro
- PMID: 11511033
- DOI: 10.1016/s0142-9612(00)00423-3
Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro
Abstract
An increasing amount of interest is focused on the potential use of tissue-engineered articular cartilage implants, for repair of defects in the joint surface. In this perspective, various biodegradable scaffolds have been evaluated as a vehicle to deliver chondrocytes into a cartilage defect. This cell-matrix implant should eventually promote regeneration of the traumatized articular joint surface with hyaline cartilage. Successful regeneration can only be achieved with such a tissue-engineered cartilage implant if the seeded cells reveal an appropriate proliferation rate in the biodegradable scaffold together with the production of a new cartilage-specific extracellular matrix. These metabolic parameters can be influenced by the biochemical composition of a cell-delivery scaffold. Further elucidation of specific cell-matrix interactions is important to define the optimal biochemical composition of a cell-delivery vehicle for cartilage repair. In this in vitro study, we investigated the effect of the presence of cartilage-specific glycosaminoglycans in a type I collagen scaffold on the metabolic activity of seeded chondrocytes. Isolated bovine chondrocytes were cultured in porous type I collagen matrices in the presence and absence of covalently attached chondroitin sulfate (CS) up to 14 days. CS did indeed influence the bioactivity of the seeded chondrocytes. Cell proliferation and the total amount of proteoglycans retained in the matrix, were significantly higher (p < 0.001) in type I collagen scaffolds with CS. Light microscopy showed the formation of a more dense cartilaginous layer at the matrix periphery. Scanning electron microscopy revealed an almost complete surfacing of the initially porous surface of both matrices. Histology and reverse transcriptase PCR for various proteoglycan subtypes suggested a good preservation of the chondrocytic phenotype of the seeded cells during culture. The stimulatory potential of CS on both the cell-proliferation and matrix retention, turns this GAG into an interesting biochemical component of a cell-delivery scaffold for use in tissue-engineering articular cartilage.
Similar articles
-
Crosslinked type II collagen matrices: preparation, characterization, and potential for cartilage engineering.Biomaterials. 2002 Aug;23(15):3183-92. doi: 10.1016/s0142-9612(02)00067-4. Biomaterials. 2002. PMID: 12102190
-
Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro.J Biomed Mater Res. 1997 Summer;38(2):95-104. doi: 10.1002/(sici)1097-4636(199722)38:2<95::aid-jbm3>3.0.co;2-b. J Biomed Mater Res. 1997. PMID: 9178736
-
EDC/NHS-crosslinked type II collagen-chondroitin sulfate scaffold: characterization and in vitro evaluation.J Mater Sci Mater Med. 2008 Feb;19(2):567-75. doi: 10.1007/s10856-007-3281-5. Epub 2007 Dec 6. J Mater Sci Mater Med. 2008. PMID: 18058201
-
Tissue Engineering: An Alternative to Repair Cartilage.Tissue Eng Part B Rev. 2019 Aug;25(4):357-373. doi: 10.1089/ten.TEB.2018.0330. Tissue Eng Part B Rev. 2019. PMID: 30913997 Review.
-
Biochemical basis of the pharmacologic action of chondroitin sulfates on the osteoarticular system.Semin Arthritis Rheum. 2001 Aug;31(1):58-68. doi: 10.1053/sarh.2000.24874. Semin Arthritis Rheum. 2001. PMID: 11503140 Review.
Cited by
-
Nanoscale modification of porous gelatin scaffolds with chondroitin sulfate for corneal stromal tissue engineering.Int J Nanomedicine. 2012;7:1101-14. doi: 10.2147/IJN.S28753. Epub 2012 Feb 23. Int J Nanomedicine. 2012. PMID: 22403490 Free PMC article.
-
Perlecan domain I promotes fibroblast growth factor 2 delivery in collagen I fibril scaffolds.Tissue Eng. 2005 Jan-Feb;11(1-2):76-89. doi: 10.1089/ten.2005.11.76. Tissue Eng. 2005. PMID: 15738663 Free PMC article.
-
Monomeric, porous type II collagen scaffolds promote chondrogenic differentiation of human bone marrow mesenchymal stem cells in vitro.Sci Rep. 2017 Mar 3;7:43519. doi: 10.1038/srep43519. Sci Rep. 2017. PMID: 28256634 Free PMC article.
-
Using chondroitin sulfate to improve the viability and biosynthesis of chondrocytes encapsulated in interpenetrating network (IPN) hydrogels of agarose and poly(ethylene glycol) diacrylate.J Mater Sci Mater Med. 2012 Jan;23(1):157-70. doi: 10.1007/s10856-011-4499-9. Epub 2011 Nov 25. J Mater Sci Mater Med. 2012. PMID: 22116661 Free PMC article.
-
Efficient Construction of Atomic-Resolution Models of Non-Sulfated Chondroitin Glycosaminoglycan Using Molecular Dynamics Data.Biomolecules. 2020 Apr 2;10(4):537. doi: 10.3390/biom10040537. Biomolecules. 2020. PMID: 32252422 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources